Literature DB >> 33270101

Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility - Chicago, Illinois, USA, May 2020.

Ashutosh Wadhwa1,2, Kiva A Fisher1,3, Rachel Silver1,4, Mitsuki Koh1,4, Melissa M Arons1,3, David A Miller1, Anne F McIntyre1, Jeni T Vuong1, Kaylee Kim1, Mayuko Takamiya1, Alison M Binder1, Jacqueline E Tate1, Paige A Armstrong1, Stephanie R Black5, Connie C Mennella6,7, Rebecca Levin8, Jane Gubser8, Bridgette Jones6,7, Sharon F Welbel7, Patrick K Moonan1, Kathryn Curran1, Isaac Ghinai1,3,5, Reena Doshi1, Chad J Zawitz6,7.   

Abstract

BACKGROUND: COVID-19 continues to cause significant morbidity and mortality worldwide. Correctional and detention facilities are at high risk of experiencing outbreaks. We aimed to evaluate cohort-based testing among detained persons exposed to laboratory-confirmed cases of SARS-CoV-2 in order to identify presymptomatic and asymptomatic cases.
METHODS: During May 1-19, 2020, two testing strategies were implemented in 12 tiers or housing units of the Cook County Jail in Chicago, Illinois. Detained persons were approached to participate in serial testing (n=137) tests at 3 time points over 14 days (day 1, day 3-5, and day 13-14). The second group was offered a single test and interview at the end of a 14-day quarantine period (day 14 group) (n=87).
RESULTS: A total of 224 detained persons were approached for participation and of these 194 (87%) participated in at least one interview, and 172 (77%) had at least one test. Of the 172 tested, 19 were positive for SARS-CoV-2. In the serial testing group, 17 (89%) new cases were detected, sixteen (84%) on day 1, one (5%) on days 3-5, and none on days 13-14; and, in day 14 group, two (11%) cases were identified. More than half (12/19; 63%) of the newly identified cases were pre-symptomatic or asymptomatic.
CONCLUSION: Our findings highlight the utility of cohort-based testing promptly after initiating quarantine within a housing tier. Cohort-based testing efforts identified new SARS-CoV-2 asymptomatic and presymptomatic infections that may have been missed by symptom screening alone. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; correctional facilities; serial testing

Year:  2020        PMID: 33270101     DOI: 10.1093/cid/ciaa1802

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Implementation of a COVID-19 Screening Testing Program in a Rural, Tribal Nation: Experience of the San Carlos Apache Tribe, January-February 2021.

Authors:  Natsai Zhou Chidavaenzi; Nickolas Agathis; Yvonne Lees; Heidi Stevens; James Clark; David Reede; Amber Kunkel; S Arunmozhi Balajee
Journal:  Public Health Rep       Date:  2022-01-13       Impact factor: 2.792

2.  The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review.

Authors:  Hannah Kim; Emily Hughes; Alice Cavanagh; Emily Norris; Angela Gao; Susan J Bondy; Katherine E McLeod; Tharsan Kanagalingam; Fiona G Kouyoumdjian
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

3.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.

Authors:  Diana Buitrago-Garcia; Aziz Mert Ipekci; Leonie Heron; Hira Imeri; Lucia Araujo-Chaveron; Ingrid Arevalo-Rodriguez; Agustín Ciapponi; Muge Cevik; Anthony Hauser; Muhammad Irfanul Alam; Kaspar Meili; Eric A Meyerowitz; Nirmala Prajapati; Xueting Qiu; Aaron Richterman; William Gildardo Robles-Rodriguez; Shabnam Thapa; Ivan Zhelyazkov; Georgia Salanti; Nicola Low
Journal:  PLoS Med       Date:  2022-05-26       Impact factor: 11.613

4.  Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.

Authors:  Qiuyue Ma; Jue Liu; Qiao Liu; Liangyu Kang; Runqing Liu; Wenzhan Jing; Yu Wu; Min Liu
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

6.  Efficacy of the Measures Adopted to Prevent COVID-19 Outbreaks in an Italian Correctional Facility for Inmates Affected by Chronic Diseases.

Authors:  Angela Stufano; Nicola Buonvino; Francesco Cagnazzo; Nicola Armenise; Daniela Pontrelli; Giovanna Curzio; Leonarda De Benedictis; Piero Lovreglio
Journal:  Front Public Health       Date:  2021-07-07

7.  SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response.

Authors:  Ourania E Tsitsilonis; Dimitrios Paraskevis; Evi Lianidou; Evangelos Terpos; Athanasios Akalestos; Vassilios Pierros; Evangelia Georgia Kostaki; Efstathios Kastritis; Paraskevi Moutsatsou; Marianna Politou; Andreas Scorilas; Thomas Sphicopoulos; Nikolaos Thomaidis; Ioannis P Trougakos; Athanassios Tsakris; Nikolaos Voulgaris; Christina C Daskalaki; Zoi Evangelakou; Christina Fouki; Despoina D Gianniou; Sentiljana Gumeni; Ioannis V Kostopoulos; Maria S Manola; Nikolaos Orologas-Stavrou; Chrysanthi Panteli; Eleni-Dimitra Papanagnou; Pantelis Rousakis; Aimilia D Sklirou; Stavroula Smilkou; Dimitra Stergiopoulou; Sotirios Tsiodras; Meletios-Athanasios Dimopoulos; Petros P Sfikakis
Journal:  Vaccines (Basel)       Date:  2021-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.